Qunli Xu

Qunli Xu serves as Vice President and Head of Translational Medicine at Astellas Pharma since April 2023, following a tenure as Executive Director, Head of Translational Science in Astellas Pharma's Global Development from April 2019 to March 2023. Prior experience includes Senior Director and Head of Translational Science at FORMA Therapeutics, and roles as Translational Medicine Lead at Takeda Pharmaceuticals, Director of Biology at Verastem Inc., and Principal Scientist at Eisai Inc. Qunli Xu's career began at Hoffmann-La Roche as a Senior Principal Scientist, with earlier roles at sanofi-aventis and as a Post-doctoral fellow at Sanford Burnham Institute. Educational qualifications include a Ph.D. in Microbiology and Immunology from Dalhousie University and a BS in Genetics and Genetic Engineering from Fudan University.